Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis

Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis

Abstract Background Novel abortive treatments for migraine, ditans and gepants, have promising implications in triptan-insufficient responders with minimal existing comparative data. Our study aims to synthesize evidence through a systematic review and network meta-analysis to assess the comparative...

Full description

Saved in:
Bibliographic Details
Main Authors: Wattakorn Laohapiboolrattana, Priabprat Jansem, Prakit Anukoolwittaya, Duangnapa Roongpiboonsopit, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Sekh Thanprasertsuk, Wanakorn Rattanawong
Format: Article
Language:English
Published: BMC 2024-11-01
Series:The Journal of Headache and Pain
Subjects:
Triptan-Insufficient Responder
Gepant
Rimegepant
Ubrogepant
Lasmiditan
Abortive Treatment
Online Access:https://doi.org/10.1186/s10194-024-01904-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s10194-024-01904-1

Similar Items